Staff Login
Japanese
| English
Contact Us
List
Search
Browse
Registration
Statistics
Search
Home
List
Reference
Patent
Reference - List
«
»
8 Hits
Search Condition : Filter (MeSH = Non-alcoholic Fatty Liver Disease / pathology)
Species
Resource
RRC ID
Title
Journal
Published
Link
Human and Animal Cells
Hep G2
69763
IL-19 Contributes to the Development of Nonalcoholic Steatohepatitis by Altering Lipid Metabolism.
Cells
2021-12-13
Pubmed
Full text
Human and Animal Cells
CACO-2(RCB0988)
67819
A Lipid-Based Nanocarrier Containing Active Vitamin D
3
Ameliorates NASH in Mice via Direct and Intestine-Mediated Effects on Liver Inflammation.
Biol Pharm Bull
2020-1-1
Pubmed
Full text
Human and Animal Cells
RAW 264(RCB0535)
63623
Hydrogen-rich water protects against liver injury in nonalcoholic steatohepatitis through HO-1 enhancement via IL-10 and Sirt 1 signaling.
Am J Physiol Gastrointest Liver Physiol
2021-4-1
Pubmed
Full text
Mice
RBRC01828
59231
Ablation of Iah1, a candidate gene for diet-induced fatty liver, does not affect liver lipid accumulation in mice.
PLoS One
2020-1-1
Pubmed
Full text
Human and Animal Cells
RAW 264(RCB0535)
58725
Dipeptidyl peptidase-4 inhibition prevents nonalcoholic steatohepatitis-associated liver fibrosis and tumor development in mice independently of its anti-diabetic effects.
Sci Rep
2020-1-22
Pubmed
Full text
Human and Animal Cells
KUP5(RCB4627)
52692
Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice.
Sci Rep
2018-5-1
Pubmed
Full text
Human and Animal Cells
Hepa 1-6(RCB1638)
52265
Mice in the early stage of liver steatosis caused by a high fat diet are resistant to thioacetamide-induced hepatotoxicity and oxidative stress.
Toxicol Lett
2017-8-5
Pubmed
Full text
Human and Animal Cells
RAW 264(RCB0535)
48065
Antifibrotic effect of pirfenidone in a mouse model of human nonalcoholic steatohepatitis.
Sci Rep
2017-3-17
Pubmed
Full text